Showing results (2311-2320 of 2,503) with videos related to

Sort By:
Pageof 251
Psychosomatic Medicine|March 10, 1998
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measuresP G Kaufmann, R P McMahon, L C Becker, et al.
Der Unfallchirurg|August 24, 2007
[Injury prevention as the physician's challenge]M Richter, G Lob, F Pühlhofer, et al.
Circulation|May 28, 2009
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial, John H Alexander, Richard C Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2014
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survivalS Ugurel, C Loquai, K Kähler, et al.
HNO|September 15, 2020
["Online from tomorrow on please": comparison of digital framework conditions of curricular teaching at national university ENT clinics in times of COVID-19 : Digital teaching at national university ENT clinics]C Offergeld, M Ketterer, M Neudert, et al.
Nature Reviews. Cardiology|January 14, 2022
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers ColloquiumDiana A Gorog, Robert F Storey, Paul A Gurbel, et al.
Nature Communications|September 5, 2019
Author Correction: Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populationsHenry R Kranzler, Hang Zhou, Rachel L Kember, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2015
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)C Kahl, R Krahl, C Becker, et al.
International Journal of Cardiology|March 7, 2018
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AFAdam S Barnett, Derek D Cyr, Shaun G Goodman, et al.
Nature Communications|April 4, 2019
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populationsHenry R Kranzler, Hang Zhou, Rachel L Kember, et al.
Pageof 251